HCM Presents Fanregratinib Data
HUTCHMED presents pivotal phase II data for fanregratinib in intrahepatic cholangiocarcinoma at ESMO Gastrointestinal Cancers Congress 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.